NewAmsterdam Pharma Company N.V. (NAMS)
NASDAQ: NAMS · Real-Time Price · USD
18.03
+0.21 (1.18%)
Nov 4, 2024, 4:00 PM EST - Market closed
NAMS Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| Nov '24 Nov 4, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| Market Capitalization | 1,623 | 920 | 889 | 139 | - |
| Market Cap Growth | 77.80% | 3.44% | 537.58% | - | - |
| Enterprise Value | 1,193 | 501 | 796 | 144 | - |
| Last Close Price | 18.03 | 11.17 | 10.90 | 9.75 | - |
| PE Ratio | - | -5.19 | -9.13 | -2.56 | - |
| PS Ratio | 211.39 | 65.26 | 8.66 | - | - |
| PB Ratio | 4.19 | 3.19 | 2.07 | 2.46 | - |
| P/FCF Ratio | -9.13 | -6.51 | 85.12 | -4.72 | - |
| P/OCF Ratio | -9.16 | -6.51 | 83.36 | -4.72 | - |
| EV/Sales Ratio | 160.67 | 35.56 | 7.75 | - | - |
| EV/EBITDA Ratio | -5.98 | -2.74 | -224.25 | -4.12 | - |
| EV/EBIT Ratio | -5.98 | -2.74 | -223.68 | -4.12 | - |
| EV/FCF Ratio | -6.59 | -3.55 | 76.18 | -4.88 | - |
| Debt / Equity Ratio | 0.00 | 0.00 | 0.00 | 0.00 | -3.26 |
| Debt / FCF Ratio | 0.00 | 0.00 | 0.01 | -0.01 | -1.95 |
| Asset Turnover | 0.02 | 0.03 | 0.38 | - | - |
| Quick Ratio | 9.63 | 6.86 | 13.03 | 5.81 | 0.61 |
| Current Ratio | 9.83 | 6.95 | 13.26 | 5.96 | 0.72 |
| Return on Equity (ROE) | -54.08% | -49.25% | -9.30% | -159.01% | - |
| Return on Assets (ROA) | -27.14% | -27.70% | -0.81% | -55.71% | - |
| Return on Capital (ROIC) | -30.72% | -31.82% | -0.91% | -66.25% | - |
| Earnings Yield | -14.13% | -19.24% | -2.55% | -29.97% | - |
| FCF Yield | -11.66% | -15.36% | 1.17% | -21.18% | - |
| Buyback Yield / Dilution | -108.42% | -333.20% | -72.75% | -119.58% | - |
| Total Shareholder Return | -108.42% | -333.20% | -72.75% | -119.58% | - |
Source: S&P Capital IQ. Standard template.
Financial Sources.